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Abstract 
A combined molecular docking and molecular structure in silico analysis on the 
substrate  and  product  of  leukotriene  A4  hydrolase  (LTA4H)  was  performed.   The 
molecular structures of the substrate leukotriene A4 (LTA4) and product leukotirene B4 
(LTB4)  were  studied  through  Density  Functional  Theory  (DFT)  calculations  at  the 
B3LYP/6-31+G(d) level of theory in both, gas and condensed phases. The whole LTB4 
molecule was divided into three fragments (hydrophobic tail, triene motif, and a polar 
acidic group) which were subjected to a full conformational study employing the most 
stable  conformations  of  them  to  build  conformers  of  the  complete  molecule  and 
geometry optimize further. LTA4 conformers structures were modeled from the LTB4 
minimum energy conformers. Both, protonated and deprotonated species of LTA4 and 
LTB4,  were  analyzed  according  to  pKa values  founded  in  the  literature.  Finally,  a 
binding model of LTA4 with LTA4 hydrolase is proposed according to docking results 
which show intermolecular interactions that position the protonated and deprotonated 
ligand in the active site, in excellent agreement with experimental data.
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Introduction 
Leukotrienes (LTs) constitute a family of endogenous metabolites of arachidonic 
acid  that  are  biosynthesized  via  the  lipoxygenase  pathway  (1-3).  These  interesting 
compounds are a class of lipid mediators involved in the development and maintenance 
of inflammatory and allergic reactions (4-7). Leukotriene A4 (LTA4), an unstable alkyl 
epoxide formed from the immediate precursor 5-HPETE via 5-lipoxygenase (5-LO) (8), 
is converted to leukotriene B4 (5S,12R-dihydroxy-6Z,8E,10E,14Z-eicosatetraenoicacid; 
LTB4,  Figure  1),   by  stereoselective  hydratation  of  LTA4 hydrolase  (LTA4H) (9). 
LTB4 is a potent pro-inflammatory mediator implicated in the pathogenesis of a number 
of diseases including inflammatory bowel disease (IBD), psoriasis, rheumatoid arthritis 
and  asthma,  and  plays  an  important  role  in  immunological  responses,  chronic 
obstructive pulmonary disease (COPD) and atherosclerosis (4,6,10-12). 
On the other hand, LTA4H is a bifunctional zinc metalloenzyme which catalyzes 
the rate limiting step in the production of LTB4 (13). The  X-ray crystal structures of 
LTA4H in complex with different inhibitors have been obtained by several authors (17-
19).  According to several investigations,  the metal site is located next to the putative 
active site bound to His295, His299, and Glu318 (14-18). 
  
In the present paper, we show an analysis of the different interactions of LTA4 
into  LTA4H  through  molecular  docking  study.  Molecular  and  electronic  structure 
information of LTA4 and LTB4, obtained from an exhaustive conformational analysis, 
was used to set an initial conformation for the docking study. 
There are few theoretical studies about the molecular structure of LTB4. One of 
them was performed by Brasseur at el. using semiempirical methods (19). They present 
a computational description of the conformation of a pair of two isomeric molecules (6-
cis  and 6-trans-leukotriene  B4) forming a  complex with one calcium ion.  Recently, 
Catoire  at  el.  have  obtained  a  highly  constrained  seahorse  conformation  when it  is 
bound to leukotriene receptor BLT2 by 1H-RMN (20). However, there has been no ab 
initio and/or  DFT studies that  analyzes  the conformation  and electronic structure of 
LTA4 and LTB4. 
Therefore,  we  believe  that  results  of  this  work  are  of  great  contribution 
especially  to  elucidate:  a)  the  structural  similitude  between LTB4 and its  precursor 
LTA4, b) the conformational changes of LTA4 in gas phase, condensed phase and when 
it  is  bounded  to  the  enzyme,  c)  the  active  site  of  LTA4H where  LTA4 binds  and 
compare it with the interaction site of inhibitors (11-13) and thus, to obtain important 
information for future development of new inhibitors of LTB4 formation.     
Material and Methods 
Conformational study
Relaxed potential  energy curves (PECs) were performed at HF/3-21G,  HF/6-
31+G(d)  and  B3LYP/6-31+G(d) levels  of  theory  (21-23),  while  potential  energy 
exploratory  surfaces  (PESs)  were  carried  out  at  HF/3-21G  level  of  theory.  The 
conformers  were  then  optimized  at  a  higher  level  and  frequency  calculations  were 
carried out to confirm minimum energy conformers checking the absence of imaginary 
frequencies.  Solvent  effect  was evaluated  through geometry  optimizations  using the 
integral  equation  formalism  polarizable  continuum  model  (IEF-PCM)  (24,25)  at 
B3LYP/6-31+G(d) level of theory. All calculations were performed using the Gaussian 
03 computational program (26). 
Molecular Docking 
Docking  calculations  were  performed  using  Autodock  Vina  software  (27)  in 
order  to  propose  a  model  of  the  LTA4-LTA4H  complex.  The  crystal  structure  of 
LTA4H used in our study was obtained from Protein Data Bank (28) (PDB accession 
code:  3CHO  (19)).  The  original  ligand,  2-amino-N-[4-(phenylmethoxy)phenyl]-
acetamide  and  water  molecules  in  the  crystal  structure  were removed.  LTA4 initial 
conformation was obtained from the conformational study. A torsional restriction was 
applied for single bonds of the conjugated system of the triene motif fragment setting 
them as fixed, i.e., not able to rotate. The box was defined to include completely the 
proposed binding site and standard parameters for the docking calculation were used 
except for exhaustiveness for which a value of 100 was used.
The  lowest  binding  energy  docking  complex  was  analyzed  with  NCIPlot 
program to identify and map noncovalent interactions using the promolecular densities 
and its derivatives. These interactions are nonlocal and manifest in real space as low-
gradient isosurfaces with low densities which are interpreted and colored according to 
the corresponding values of sign(λ2)ρ (29).
Results and Discussions 
Conformational study for LTB4 
To obtain the structure of LTA4 for the docking study, we previously performed 
a conformational analysis on LTB4, which optimized structure was used to propose the 
initial conformation of LTA4 for the molecular docking study.
Several  papers  agree  that  LTB4  is  a  cis-trans  (or  E-Z)  isomers  (5S,12R-
dihydroxy-6Z,8E,10E,14Z-eicosatetraenoicacid)  (19,20,30)  and  that  LTB4  show 
conformational  restrictions  in  the  double  bonds  configuration  of  LTB4 
(6Z,8E,10E,14Z). Despite the restrictions of double bonds, the molecule of LTB4 has 
13 rotational bonds, and if these dihedrals were affected by systematic 120º changes, 
more than 1.500x103 conformations could be obtained. To avoid this large number of 
possible  conformations,  a systematic  analysis  was realized  in  a  stepwise manner  on 
three different important fragments of the LTB4 easily recognizable: a) hydrophobic tail 
b) a triene motif and c) a polar group (Figure 2). Our systematic study includes a severe 
analysis  of  each fragment  which was selected  based on its  chemical  characteristics. 
Molecular fragmentation have been used in previous work of our group given excellent 
results in the study of large molecules (31,32). 
Hydrophobic tail
This fragment is composed by a chain of methylens units which is bound to the 
triene fragment through a double bond. Conformational study of this fragment consisted 
in the analysis of the four dihedral angles presented in Figure 2a. Rotating dihedrals 
φ1 and φ4 two potential energy curves were obtained (Figure 3a and b). The plots present 
the global energy minimum around 180º for φ1 and two local minima next to 120º and 
-120º with the same energy for φ4. PES of the type E=f(φ2,φ3)  shows a global minimum 
with  dihedral  values  of  about  φ2=180º and  φ3=180º.  This  is  show in  supplementary 
material, Figure 1S.  
We have found that the hydrophobic tail fragment has high symmetry and an 
elongated minimum energy conformation with dihedral values next to 180º for φ1, φ2, φ3, 
and 120º or -120º for  φ4. However, the low rotational barriers (less than 3 kcal.mol-1) 
indicate that this fragment has a high conformational flexibility.
Triene motif 
Although the conjugated triene system confers the fragment a high rigidity, there 
are dihedral angles that deserve to be analyzed:  φ5,  φ6  and  φ7, Figure 2. In contrast to 
these dihedrals angles, the values of dihedral φ8 depend largely on the fragment with the 
acidic  function.  So,  we  believe  that  the  analysis  of  this  dihedral  has  no  practical 
meaning at this point. 
Dihedral  angle  φ5 was  studied through a PEC, Figure 3c.  The global  energy 
minimum has the double bond in opposite position respect to the OH group, next to 
120º, where no interaction occurs, but probably torsional tension is relieved. PES of the 
type E=f(φ6,  φ7) shown in supporting information as Figure 1S,  presents the global 
minimum on the region of  φ6  ≈ 180º and φ7  ≈ -120º. However, there are local minima 
with rotational barriers of about 3 kcal.mol-1  and energy values close to global energy 
minimum. The low rotational barrier confers a relatively flexibility, that would only be 
restrained in the complete LTB4 molecule by steric repulsion.
Polar (Acidic) group
This  fragment  is  characterized  by  an  OH group over  a  quiral  carbon  and a 
carboxylic  group,  both  separated  by  three  methylene  groups.  Due to  the  methylene 
chain, the fragment presents a high flexibility in the dihedral angles φ9, φ10, φ11 and φ12. A 
similar  analysis  to  the others  fragment  was performed to the dihedral  angles  of  the 
present fragment, briefly: PECs were made for dihedrals φ9 and φ12, while dihedrals φ10 
and φ11 were analyzed through PES.
In Figure 3d is identified the zone of the highest energy (φ9 ≈ 0º, repulsion zone) 
and zones of minimum energy (φ9  ≈ 180º, global minimum energy and φ9  ≈ 60º,  ∆E = 
0.1 kcal.mol-1).  PES obtained from  φ10  and φ11,  plotted in Figure 1S, shows that  the 
global energy minimum is localized next to 60º for both, φ10 and φ11. The low rotational 
barriers between any of the two minima indicate the high flexibility of the fragment.
Furthermore,  rotation of dihedrals  φ12  and φ13  produces a series of conformers 
with  intramolecular  hydrogen bond interactions.  Consequently,  a  NBO analysis  was 
performed on these conformations. In addition, taking into consideration the values of 
pKa for leukotrienes  range from 3 to  5 (33,34),  deprotonated species  should also be 
studied.  Table  1 presents  the three potential  conformations  for acidic  group in both 
species obtained from DFT calculations. The total energy indicates that both species of 
the  first  conformer  are  the  most  stable  conformations.  The  interaction  energy  E(2) 
between donor and acceptor orbitals show an effective interaction between the oxygen 
lone pairs (LP) and the sigma antibonding orbitals (σ*) of O–H bond which is higher in 
the  deprotonated  species  (no  charge  transfer  interaction  was  founded  in  the  last 
conformer  for  the  anionic  species).  Although  the  third  acidic  conformer  presents  a 
higher  charge  transfer  stabilization  energy,  steric  restraints  could  disfavor  this 
conformation.
Molecular structure for LTB4 
Using the minimum energy conformers of the three fragments we proposed an 
initial  molecular  structure for LTB4. However,  its  stable  conformation  could be the 
same or different to structure proposed. Figure 4 shows the superposition of the most 
stable conformer and molecular structure obtained from the fragmentary study.  The 
principal  difference  of  both structures  is  the values  of  dihedral  angle  φ8.  The value 
proposed for φ8 in the initial structure was of 180º (Figure 4, in dark gray) while full  
optimized value is  -125º (Figure 4,  in  light  gray)  giving rise  to  a  ∆E between both 
structures of about 35 kcal.mol-1. This result is expected because dihedral  φ8 was not 
analyzed in the fragmentary analysis. Consequently, dihedral value was modified when 
the whole molecule was fully optimized.
Molecular structure for LTA4 
LTB4 shows a high structural similarity to its precursor the leukotriene A4. The 
most important structural difference resides in the presence of an epoxy group in LTA4 
molecule.  This  epoxy  group is  hydrolyzed  and  converted  into  an  OH group in  the 
enzymatic step that involves the formation of LTB4 (13-18).
To obtain  a  stable  conformation  for  LTA4,  which can be used in  molecular 
docking study, we suggested an initial conformation using the dihedral values of LTB4. 
Hydrophobic tail dihedral initial values were taken from the most stable conformation 
of  LTB4.  In  addition,  literature  suggests  a  7E,  9E,  11Z,  14Z configuration  for  the 
unsaturated part of LTA4 (8). However, dihedrals  θ1 and  θ2 of LTA4, Figure 5, are 
involved  in  the  orientation  of  the  epoxy  group  which  plays  a  key  role  in  enzyme 
binding. Consequently, to perform a complete analysis, these important dihedrals were 
studied. 
 
A full optimization carried out for the four possible conformers gave low energy 
differences between all conformers, Figure 2S in supporting information. Solvent effect 
analysis indicates that the stable conformations obtained in vacuo are not altered by the 
presence of the solvent. 
Molecular Docking
A molecular  docking  study was  performed  to  propose  a  binding  model  and 
interpret  the different  interactions between the ligand and the enzyme. Although the 
reaction  mechanism  proposed  by Thunnissen et  al.  (14)  involves  the  deprotonated 
species  of  LTA4,  both,  the  acidic  and  anionic  species  of  LTA4,  were  subjected  to 
docking studies.
Nine possible binding complexes were obtained for the anionic species of LTA4. 
The most stable one, i.e. the one with lowest ∆G of binding (about -9.5 kcal.mol-1), is 
shown in Figure 6. The model reveals that the carboxylate group interacts with Arg563 
and is close to Lys565; the epoxide is positioned with the oxygen atom coordinating 
with Zn2+ cation and forming a square based pyramidal metal complex with His 295, 
His 299 and Glu 318 (14); the hydrophobic tail is buried in a hydrophobic pocket; and 
Asp375 is oriented toward the triene group where it would control the position of a 
water molecule and therefore the stereospecific insertion of the 12R-hydroxyl group of 
LTB4 as is proposed in the literature according to the reaction mechanism presented 
(14-18).
The most stable docking complex of the enzyme and the acidic species of LTA4 
presents the substrate located in the same cavity and with almost the same orientation 
that was founded for the anionic one (Figure 6). Moreover,  ∆G of binding is only 0.1 
kcal.mol-1 higher.
Figure 6 also shows a complex web of weak noncovalent interactions between 
the substrate and the active site of the enzyme (including the Zn2+ cation) where van der 
Waals  and  hydrophobic  interactions  dominate  by  far  (green  surfaces).  Moreover, 
interaction analysis reveals a hydrogen bond between the carboxylate group of LTA4 
and  Arg563.  In  the  proposed  binding  model  LTA4  do  not  interact  with  Lys565. 
However, we expect that the dynamic behavior of both, the substrate and the enzyme, 
leads to the formation of a hydrogen bond (or more probably a salt bridge) between 
LTA4 and the positively charged residue Lys565 due to it is close to Arg563 in the 
binding site. 
LTA4 minimum energy conformation from quantum analysis shows differences 
with enzyme-bounded conformation (Figure 7). However, it is well known that flexible 
molecules  change their  conformation  upon binding to  a  protein  (35),  thus,  it  is  not 
surprising our finding if we take into account the high degree of flexibility of LTA4 
molecule.
Conclusions
We obtained from conformational analysis the stable structures for the substrate 
and product of the enzyme LTA4H using Hartree Fock and DFT calculations.  Most 
stable  conformation  of  LTB4  shows  an  elongated  structure  with  an  intramolecular 
interaction in the polar fragment analyzed through NBO analysis. Based in the structural 
data of LTB4 four possible conformations of LTA4 were proposed. We founded that 
conformer IV is the most stable in gas and solvated phases with a ∆E of 1 kcal.mol-1 less 
than the other conformers. 
Molecular docking results provided an interaction model of LTA4 with LTA4H 
in excellent correlation with the experimental data: the substrate fits in the active site of 
the  enzyme  arranging  its  functional  groups  according  to  the  reaction  mechanism 
proposed  by  several  authors  (14-17).  Both  species  of  LTA4,  protonated  and 
deprotonated, bind to the same site with proper orientation of the key groups for the 
enzymatic reaction. The substrate is held in the active site by multiple weak attractive 
interactions along its surface and a hydrogen bond to Arg563.
Thus, the  in silico  model of LTA4-LTA4H complex obtained from molecular 
docking in combination with a conformation analysis of substrate and product provides 
insights into the development of new and most efficient inhibitors of LTB4 formation.
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Figure Legends
Figure 1: Reaction catalyzed by LTA4H. Chemical structures of LTA4 and LTB4.  
Figure 2:  Structure of LTB4 (5S,12R-dihydroxy-6Z,8E,10E,14Z-eicosatetraenoicacid). 
Scheme of fragments of LTB4 and dihedral studies: a) hydrophobic tail, b) triene motif, 
c) polar group. 
Figure 3: Curves energy potential for; a) and b) hydrophobic tail, c) triene motif and d) 
acidic part.
Figure 4:  Overlap of the most stable conformer of LTB4 (light gray sticks) and 
molecular structure obtained from the fragmentary study (dark gray sticks).
Figure 5: Molecular structure for LTA4 (5S,6S-epoxy-7E,9E,11Z,14Z-eicosatetraenoic 
acid).
Figure 6:  Model of LTA4 anion bounded to LTA4H. Docked complex showing the 
side chains of the amino acids involved in the reaction mechanism proposed (left panel). 
Combined docking results of acidic and anionic species of LTA4 (upper right panel). 
Noncovalent  interactions  of  the  LTA4  anion  within  the  binding  pocket  of  LTA4H 
(lower  right  panel).  Blue  indicates  strong  attractive  interactions  and  green  van  der 
Waals (weak attractive) interactions.
Figure  7: Overlap  of  the  most  stable  conformer  of  LTA4  (dark  gray  sticks)  and 
molecular structure obtained from the molecular docking study (light gray sticks). 
Table1: Conformational and electronic dates obtained by rotation of dihedrals φ12 and 
φ13 for polar fragment.
Form φ12 φ13 E(2)a
kcal.mol-1
Total Energyb
(Hartree)
∆E 
kcal.mol-1
Protonated -77.70º -178.70º
LP(1) 2.06 
LP(2) 5.34
-461.5722022 0.0
Deprotonated -77.84º -
LP(1) 6.98 
LP(2) 34.67
-461.0349725
Protonated 86.96º 179.52º LP(1) 2.92 -461.5698006 1.50
Deprotonated 100.69º -
LP(1) 6.98 
LP(2) 34.67
-461.0349725
Protonated 94.72º 3.01º LP(2)16.83 -461.5702739 1.21
Deprotonated 15.06 - Not founded -461.0181532
a E(2) means energy of hyper conjugative interaction (stabilization energy). LP: Lone Pair 
b Total energy of conformer in Hartree (1hartree=627.5095 kcal.mol-1). 
Table 2: Energy and structural dates for the conformers of LTA4. 
HF/6-31+G(d) B3LYP/6-31+G(d) IEF-PCM/ B3LYP/6-31+G(d)
θ1 θ2
∆E
(kcal.mol-1)
θ1 θ2
∆E
(kcal.mol-1)
θ1 θ2
∆E
(kcal.mol-1)
I -72.58 93.46 2.25 -66.52 92.92 2.33 -63.82 93.57 2.19
II -73.72 -148.45 0.62 -67.36 -147.62 1.00 -64.25 -152.00 1.65
III 148.23 92.08 1.69 151.11 91.49 1.40 153.48 91.35 0.60
IV 148.03 -149.07 0 150.28 -149.90 0 154.00 -153.16 0
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Figure 1S:  Potential  energy surfaces: A) E=f(φ3,φ4) hydrophobic tail,  B) E=f(φ6,φ7) 
triene motif, C) E=f(φ10,φ11) polar group.  
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